• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基脲在基于患者诱导多能干细胞的迟发性帕金森病模型中促进疾病相关表型的显现。

Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease.

作者信息

Tan Yuan, Ke Minjing, Huang Zhijian, Chong Cheong-Meng, Cen Xiaotong, Lu Jia-Hong, Yao Xiaoli, Qin Dajiang, Su Huanxing

机构信息

1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.

2South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

出版信息

Aging Dis. 2019 Oct 1;10(5):1037-1048. doi: 10.14336/AD.2018.1216. eCollection 2019 Oct.

DOI:10.14336/AD.2018.1216
PMID:31595201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6764725/
Abstract

Induced pluripotent stem cells (iPSCs)-derived dopaminergic neurons might be reset back to the fetal state due to reprogramming. Thus, it is a compelling challenge to reliably and efficiently induce disease phenotypes of iPSCs-derived dopaminergic neurons to model late-onset Parkinson's disease (PD). Here, we applied a small molecule, hydroxyurea (HU), to promote the manifestation of disease relevant phenotypes in iPSCs-based modeling of PD. We established two iPS cell lines derived from two sporadic PD patients. Both patients-iPSCs-derived dopaminergic neurons did not display PD relevant phenotypes after 6 weeks culture. HU treatment remarkably induced ER stress on patients-iPSCs-derived dopaminergic neurons. Moreover, HU treatment significantly reduced neurite outgrowth, decreased the expression of p-AKT and its downstream targets (p-4EBP1 and p-ULK1), and increased the expression level of cleaved-Caspase 3 in patients-iPSCs-derived dopaminergic neurons. The findings of the present study suggest that HU administration could be a convenient and reliable approach to induce disease relevant phenotypes in PD-iPSCs-based models, facilitating to study disease mechanisms and test drug effects.

摘要

诱导多能干细胞(iPSC)来源的多巴胺能神经元可能由于重编程而恢复到胎儿状态。因此,在可靠且高效地诱导iPSC来源的多巴胺能神经元出现疾病表型以模拟迟发性帕金森病(PD)方面,这是一项极具挑战性的任务。在此,我们应用一种小分子——羟基脲(HU),以促进在基于iPSC的PD模型中与疾病相关表型的显现。我们建立了源自两名散发性PD患者的两条iPS细胞系。在培养6周后,这两名患者的iPSC来源的多巴胺能神经元均未表现出与PD相关的表型。HU处理显著诱导了患者iPSC来源的多巴胺能神经元的内质网应激。此外,HU处理显著减少了神经突生长,降低了p-AKT及其下游靶点(p-4EBP1和p-ULK1)的表达,并增加了患者iPSC来源的多巴胺能神经元中裂解的半胱天冬酶3的表达水平。本研究结果表明,给予HU可能是在基于PD-iPSC的模型中诱导与疾病相关表型的一种便捷且可靠的方法,有助于研究疾病机制和测试药物效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/cd75a9dbabaa/ad-10-5-1037-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/771d833d3dde/ad-10-5-1037-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/1916271d9614/ad-10-5-1037-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/d494f78b4750/ad-10-5-1037-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/b626b10ad107/ad-10-5-1037-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/cd75a9dbabaa/ad-10-5-1037-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/771d833d3dde/ad-10-5-1037-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/1916271d9614/ad-10-5-1037-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/d494f78b4750/ad-10-5-1037-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/b626b10ad107/ad-10-5-1037-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec5/6764725/cd75a9dbabaa/ad-10-5-1037-g5.jpg

相似文献

1
Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease.羟基脲在基于患者诱导多能干细胞的迟发性帕金森病模型中促进疾病相关表型的显现。
Aging Dis. 2019 Oct 1;10(5):1037-1048. doi: 10.14336/AD.2018.1216. eCollection 2019 Oct.
2
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.使用患者来源的诱导多能干细胞来鉴定帕金森病相关表型。
Curr Neurol Neurosci Rep. 2018 Oct 4;18(12):84. doi: 10.1007/s11910-018-0893-8.
3
Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.细胞黏附分子对诱导多能干细胞源性多巴胺能神经元轴突生长的影响
Cell Reprogram. 2016 Apr;18(2):55-66. doi: 10.1089/cell.2015.0059. Epub 2016 Mar 18.
4
Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.从帕金森病患者中生成嗜幼稚型诱导多能干细胞用于高效基因操作和疾病建模。
Stem Cells Dev. 2015 Nov 1;24(21):2591-604. doi: 10.1089/scd.2015.0079. Epub 2015 Sep 1.
5
Using induced pluripotent stem cells for modeling Parkinson's disease.利用诱导多能干细胞建立帕金森病模型。
World J Stem Cells. 2019 Sep 26;11(9):634-649. doi: 10.4252/wjsc.v11.i9.634.
6
A compendious summary of Parkinson's disease patient-derived iPSCs in the first decade.帕金森病患者来源的诱导多能干细胞十年研究简况
Ann Transl Med. 2019 Nov;7(22):685. doi: 10.21037/atm.2019.11.16.
7
Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology.帕金森病建模:诱导多能干细胞助力深入了解人类病理学
Brain Sci. 2021 Mar 14;11(3):373. doi: 10.3390/brainsci11030373.
8
In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study.人诱导多能干细胞在家族性帕金森病的体内表型研究:概念验证研究。
Neurochem Res. 2019 Jun;44(6):1475-1493. doi: 10.1007/s11064-019-02781-w. Epub 2019 Apr 15.
9
An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson's Disease.一种将诱导多能干细胞高效分化为成熟有丝分裂后多巴胺能神经元的二维方案:在帕金森病建模中的应用
Int J Mol Sci. 2023 Apr 14;24(8):7297. doi: 10.3390/ijms24087297.
10
The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease.诱导多能干细胞作为帕金森病模型的研究进展
Stem Cells Int. 2016;2016:4126214. doi: 10.1155/2016/4126214. Epub 2016 Jan 6.

引用本文的文献

1
Optimization of Application-Driven Development of Neuromuscular Junction Models.应用驱动的神经肌肉接头模型开发的优化。
Tissue Eng Part B Rev. 2022 Dec;28(6):1180-1191. doi: 10.1089/ten.TEB.2021.0204. Epub 2022 Aug 1.
2
Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.人诱导多能干细胞衍生多巴胺神经元在帕金森病药物研发中的应用:现状与未解决问题
Int J Mol Sci. 2021 Mar 25;22(7):3381. doi: 10.3390/ijms22073381.
3
Comprehensive Perspectives on Experimental Models for Parkinson's Disease.

本文引用的文献

1
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease.衰老与脂多糖暴露在帕金森病小鼠模型中的协同作用
Aging Dis. 2018 Oct 1;9(5):785-797. doi: 10.14336/AD.2017.1028. eCollection 2018 Oct.
2
Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson's Disease.岩藻依聚糖通过增强线粒体功能在鱼藤酮诱导的帕金森病大鼠模型中保护多巴胺能神经元。
Aging Dis. 2018 Aug 1;9(4):590-604. doi: 10.14336/AD.2017.0831. eCollection 2018 Aug.
3
SIRT3 Protects Rotenone-induced Injury in SH-SY5Y Cells by Promoting Autophagy through the LKB1-AMPK-mTOR Pathway.
帕金森病实验模型的综合视角
Aging Dis. 2021 Feb 1;12(1):223-246. doi: 10.14336/AD.2020.0331. eCollection 2021 Feb.
4
Effectiveness of Acupuncture in the Treatment of Parkinson's Disease: An Overview of Systematic Reviews.针灸治疗帕金森病的有效性:系统评价概述
Front Neurol. 2020 Aug 25;11:917. doi: 10.3389/fneur.2020.00917. eCollection 2020.
5
Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.阿佐酰胺通过恢复内质网功能和 CREB 信号来保护 PLA2G6 D331Y 突变诱导的 iPSC 衍生多巴胺能神经元。
Cell Death Dis. 2020 Feb 18;11(2):130. doi: 10.1038/s41419-020-2312-8.
6
Using induced pluripotent stem cells for modeling Parkinson's disease.利用诱导多能干细胞建立帕金森病模型。
World J Stem Cells. 2019 Sep 26;11(9):634-649. doi: 10.4252/wjsc.v11.i9.634.
SIRT3通过LKB1-AMPK-mTOR途径促进自噬,保护鱼藤酮诱导的SH-SY5Y细胞损伤。
Aging Dis. 2018 Apr 1;9(2):273-286. doi: 10.14336/AD.2017.0517. eCollection 2018 Apr.
4
Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy.将退行性衰老视为一种可治疗的医学病症:方法与政策
Aging Dis. 2017 Oct 1;8(5):583-589. doi: 10.14336/AD.2017.0130. eCollection 2017 Oct.
5
A stress-induced cellular aging model with postnatal neural stem cells.一种利用产后神经干细胞构建的应激诱导细胞衰老模型。
Cell Death Dis. 2017 Sep 7;8(9):e3041. doi: 10.1038/cddis.2017.445.
6
On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.能量代谢、蛋白质稳态、衰老与帕金森病之间的关系:甲基乙二醛的可能致病作用及肌肽的缓解潜力
Aging Dis. 2017 May 2;8(3):334-345. doi: 10.14336/AD.2016.1030. eCollection 2017 May.
7
Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.冷冻保存维持人诱导多能干细胞多巴胺能神经元的功能,并在体内挽救帕金森病表型。
Stem Cell Reports. 2017 Jul 11;9(1):149-161. doi: 10.1016/j.stemcr.2017.04.033. Epub 2017 Jun 1.
8
Endoplasmic reticulum proteostasis impairment in aging.衰老过程中的内质网蛋白质稳态损伤
Aging Cell. 2017 Aug;16(4):615-623. doi: 10.1111/acel.12599. Epub 2017 Apr 23.
9
Drug-induced premature senescence model in human dental follicle stem cells.人牙囊干细胞的药物诱导早衰模型
Oncotarget. 2017 Jan 31;8(5):7276-7293. doi: 10.18632/oncotarget.14085.
10
ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.内质网应激与帕金森病:汇聚于分泌途径的病理输入。
Brain Res. 2016 Oct 1;1648(Pt B):626-632. doi: 10.1016/j.brainres.2016.04.042. Epub 2016 Apr 19.